Industries > Pharma > Translational Regenerative Medicine Market Forecast 2020-2030

Translational Regenerative Medicine Market Forecast 2020-2030

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 31 January 2020
PAGES: 338
PRODUCT CODE: PHA0670

Clear
WOOCS 2.2.1

covid-19

The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 59% in 2019.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will find 338-page report and you will receive 116 tables, 104 figures and 3 interviews – all unavailable elsewhere.

The 338-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Translational Regenerative Medicine market forecasts from 2020-2030

• Global Translational Regenerative Medicine submarket forecasts from 2020-2030 covering:
• Stem Cell Therapies
• Tissue Engineered Products
• Gene Therapies

This study discusses the late-stage clinical trials and pipeline as well as market drivers and restraints of each submarket.

• Translational Regenerative Medicine regional and national market forecasts from 2020-2030, covering:
• North America: US, Canada
• Europe: Germany, France, UK, Italy, Spain, Rest of Europe
• Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: GCC Countries, South Africa, Rest of Middle East & Africa

Translational Regenerative Medicine Market Forecast 2020-2030

Each regional market is further segmented by sector.

• Forecasts from 2020-2030 of the selected leading products in the Global Translational Regenerative Medicine market:
• Osteocel Plus
• Trinity ELITE
• TEMCELL /Prochymal
• Apligraf
• Dermagraft
• Epifix
• ReCell
• Neovasculgen
• IMLYGIC (talimogene laherparepvec)

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen, Inc.
• MEDIPOST Co., Ltd.
• NuVasive
• Organogenesis Holdings, Inc.
• Osiris Therapeutics, Inc.
• Pharmicell Co., Ltd.
• Takeda
• uniQure N.V.
• Vericell Corporation

• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Translational Regenerative Medicine Market: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Translational Regenerative Medicine Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

READ

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Categories